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Abstract
Whether the FTO polymorphisms interact with environmental factors has not yet been evaluated in associations with metabolic syndrome (MS)
risk. The present study investigated the association of the FTO rs9939609 genotypes, body mass index (BMI), and lifestyle-related factors including
smoking, alcohol drinking, physical activity, and diet with MS incidence. A population-based prospective cohort study comprised 3,504 male and
female Koreans aged 40 to 69 years. At the beginning of the study, all individuals were free of MS and known cardiovascular disease. Incident
cases of MS were identified by biennial health examinations during a follow-up period from April 17, 2003 to April 15, 2009. Pooled logistic 
regression analysis was applied to obtain relative odds (RO) of MS with its 95% confidence interval (CI). After controlling for potential MS risk
factors, we observed no association between the rs9939609 genotypes and MS incidence. In analysis stratified by BMI, however, carriers with the
FTO risk allele whose BMI is 29 kg/m
2 or greater showed an approximately 6-fold higher RO (95% CI: 3.82 to 9.30) compared with non-carriers
with BMI less than 25 kg/m
2. In particular, the association between the rs9939609 variants and MS risk was significantly modified by high BMI
(P-value for interaction < 0.05). Such significant interaction appeared in associations with central obesity and high blood pressure among the MS
components. Because carriers of the FTO risk alleles who had BMI of 29 kg/m
2 or greater are considered a high risk population, we suggest that
they may need intensive weight loss regimens to prevent MS development.
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Introduction11)
The common variants in fat mass and obesity associated gene 
(FTO) were first discovered in associations with type 2 diabetes 
[1] but were replicated by subsequent studies as susceptible loci 
associated with obesity [2-4] rather than with diabetes [5]. 
Successful replications of the association between variants in 
FTO and body weight have been demonstrated mainly among 
populations from European ancestry [2-5]. In particular, the 
rs9939609 single nucleotide polymorphism (SNP), which is 
located within the first intron of FTO, has been most extensively 
studied and was found to have a strong association with body 
mass index (BMI) [1,2,4]. However, findings on the associations 
of rs9939609 and further FTO SNPs with obesity have been 
inconsistent among Asian populations [5,6-12].
The prevalence of metabolic syndrome (MS) increasingly 
affects Asian adults and its prevalence ranges 10% to 19% [13]. 
Each of MS traits including obesity, dyslipidemia, high blood 
pressure, and elevated fasting glucose levels is well-known as 
a cardiovascular risk factor and the clustering of these features 
apparently elevates mortality of cardiovascular disease [14]. 
Although obesity and MS do not completely overlap, obesity 
is considered the core of MS and thus the FTO has been selected 
as a candidate gene related to MS in a study including European 
individuals [15]. On the basis of accumulated data on blood 
pressure and indicators of glucose and lipid metabolism, 
furthermore, carriers of the A-risk allele at rs9939609 are likely 
to have higher blood pressure [16,17], lower HDL cholesterol 
levels in blood [18-20], and higher blood glucose [20]. In 
contrast, some studies showed no association of the FTO variants 
with any MS trait as well as with the MS clustering [21-25]. 
There is only one prospective follow-up study by which a 
significant association between the FTO variants and the risk 
of MS was reported among Swedish individuals [15]. For Asian 
populations, however, there is currently a paucity of research 
for MS prevalence [18,25] and none for MS incidence in 
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associations with the FTO variants. Furthermore, interactions 
between the FTO variants and lifestyle-related factors including 
smoking, alcohol drinking, sedentary lifestyle, and diet on MS 
incidence have not yet been evaluated so far. With genetic 
predisposition, sedentary lifestyle or higher intake of total energy 
and specific macronutrients may contribute to the development 
of MS.
The aim of present study was to investigate prospectively the 
future development of MS depending on the FTO rs9939609 
genotypes and examine whether BMI and lifestyle-related factors 
modify the association between the FTO variants and MS 
incidence in population-based cohorts composed of Korean 
adults.
Subjects and Methods
Study population
The present study is based on two population-based prospective 
cohort studies, which are ongoing investigations embedded 
within the Korean Genome Epidemiology Study (KoGES) with 
a goal of conducting genome-wide association studies (GWAS). 
Detailed information on the population and method of each 
cohort study and the procedures of GWAS is available in 
previous reports [26,27]. One cohort study has been conducted 
at the Korea University Ansan Hospital and the other study at 
the Ajou University Medical Center. All members of both cohorts 
are Korean adults with the same ethnic background and were 
aged 40 to 69 years at baseline. The baseline examinations of 
both studies started from June 18, 2001 and were completed by 
January 29, 2003. During the site visit, all participated in a 
comprehensive health examination including anthropometric 
evaluation and collection of biospecimens for assays as well as 
in a questionnaire-based interview. They have been followed 
biennially up with a scheduled site visit for similar interviews 
and health examinations administered by trained health 
professionals. Major questionnaires including lifestyle-related 
factors and technical procedures of both cohort studies are 
periodically standardized. At each visit, participants sign an 
informed consent form, which was approved by the Human 
Subjects Review Committee either at the Korea University Ansan 
Hospital or at the Ajou University Medical Center.
For the study population of this investigation, we selected 
5,459 individuals, who were free of metabolic syndrome or 
cardiovascular disease and who had acceptable genotype data that 
passed quality control and who provided information on 
lifestyle-related factors and adequate dietary intake (calorie intake 
that falls inside of five standard deviations), on the basis of 
baseline data. 
Definition of the metabolic syndrome
The metabolic syndrome is defined as the presence of three 
or more of five traits including high concentrations of serum 
triglycerides (≥150 mg/dL or use of medications due to 
dyslipidemia), low concentrations of serum HDL cholesterol (< 
40mg/dL for men and < 50 mg/dL for women), high blood 
pressure (systolic/diastolic pressure ≥130/85 mmHg or use of 
antihypertensive medications), and high concentrations of fasting 
glucose (≥100 mg/dL or use of medications due to elevated 
glucose) [28]. In addition, central obesity given as waist 
circumference is also considered a MS trait and defined as > 
85 cm for men and > 80 cm for women. Such waist circumference 
cutoff points have been suggested to be optimal for MS diagnosis 
among Korean adults [29]. Because the data of follow-up 
examinations and interviews from April 17, 2003 to April 15, 
2009 were technically validated, information on incident cases 
of MS as the outcome of present study was collected over 6 
years.
Genetic and biochemical analyses
Genotyping of the FTO rs9939609 polymorphisms was carried 
out as part of GWAS procedure as reported in a previous study 
[12]. This published report provides detailed information on 
preparation of genomic samples, genotyping method, and quality 
control for data [12]. Briefly, participants had fasted for at least 
8 hours before the beginning of blood collection for genotyping 
and biochemical analyses. Genomic DNA was collected from 
blood samples and 500 ng of DNA was processed according to 
the Affymetrix Genome-wide Human SNP array 5.0 (Affymetrix, 
Inc., Santa Clara, CA, USA). The genotyping call rates were 
greater than 95% and the genotype distribution of rs9939609 SNP 
was in Hardy-Weinberg equilibrium (HWE) (P-value = 0.31).
Biochemical assays for serum triglycerides and HDL cholesterol 
and plasma glucose were conducted at baseline as well as during 
the follow-up examinations. The laboratory reported inter-assay 
coefficient variations from routine assays; 5.2% for triglycerides, 
3.8% for HDL cholesterol, and 2.8% for glucose.
Health examination and interview on lifestyle-related factors
Comprehensive health examinations and questionnaire-based 
interviews were periodically conducted. To evaluate obesity, 
participant’s height (cm) and body weight (kg) were measured 
to the nearest 0.1 cm or 0.1 kg, respectively, and his or her 
BMI was calculated as weight in kilograms divided by height 
in meters squared. Waist circumference (cm) was measured at 
the narrowest part between the lower rib and the iliac crest to 
the nearest 0.1 cm and the average of three repeated 
measurements was calculated. Blood pressure was measured in 
a sitting position with mercury sphygmomanometers after at least 
a 5 minute period of rest. Repeated measurements of blood 80 FTO polymorphism and metabolic syndrome incidence
Characteristics
FTO rs9939609 genotypes
P-value
TT TA AA
N of participants 
(allele frequency)
3,562 (0.776) 956 (0.208) 72 (0.016)
Age (yrs) 51.0 ± 8.7
1) 51.0 ± 8.8 48.7 ± 7.5 0.09
Men (%) 48.9  48.4  50.0  0.95
Body mass index 
(kg/m
2)
23.6 ± 2.8 24.1 ± 2.9 23.7 ± 2.5 < 0.001
Occupation (%)
  Office job 9.3  8.7  6.9  0.67
  Non-office job 90.3  91.1  91.7  0.73
Low income
2) (%) 29.6  30.1  25.0  0.65
Educational level of 
> 9 years (%)
51.0 50.5 43.1  0.41
Current smokers (%) 26.6  25.9  23.6  0.80
Current drinkers (%) 50.3  49.6  54.2  0.74
Alcohol consumed 
among drinkers (g/day)
10.0 ± 24.0 9.9 ± 22.9 10.1 ± 23.3 0.98
Physical activity
3) 
(MET-hours/day)
31.2 ± 15.2 29.9 ± 15.0 32.0 ± 16.7 0.06
Average daily intakes
  Total energy 
(kcal/day)
1,873.3 ± 588.7 1,880.1 ± 571.2 1,875.7 ± 486.2 0.95
  Carbohydrate (g) 329.2 ± 98.8 327.9 ± 94.9 330.2 ± 73.0 0.93
  Fat (g) 30.8 ± 17.5 31.7 ± 17.0 31.0 ± 17.5 0.33
  Protein (g) 63.9 ± 25.3 64.8 ± 24.6 62.4 ± 23.0 0.49
Study site of the 
Ansan cohort
4) (%)
56.5 57.3 55.6  0.89
1) Mean ± SD
2) Average  monthly  wage  < 10
6  won,  which  approximately  corresponds  to  the 
government-set-minimum  wage  for  a  family  of  three  persons.
3) Total  metabolic  equivalent  was  calculated  for  daily  physical  activity
4) Because  present  study  includes  data  from  the  Ansan  cohort  and  the  Ansung 
cohort,  the  study  site  is  considered  as  a  covariate. 
Table 1. Comparison of characteristics according to the FTO rs9939609 
genotypes
pressure were performed after about a 30 second interval and 
recorded to the nearest 2 mmHg. The average of measurements 
was calculated for systolic and diastolic blood pressure.
The questionnaire requested information on lifestyle-related 
factors such as smoking, alcohol drinking, physical activity, and 
dietary intake. The method of calculation for average daily 
alcohol consumption (g/day) and total metabolic equivalent 
scores (MET/hour) for physical activity has been described 
elsewhere [26]. Dietary information was collected using a 
semi-quantitative food frequency questionnaire (FFQ), which was 
developed by the Korea Centers for Disease Control and 
Prevention (Seoul, Korea). For the recall of food items or 
beverages consumed in the previous year, participants were asked 
to complete the FFQ table with inquiries about information on 
the average consumption frequency and serving size for 103 food 
items. During the interview with the FFQ, trained interviewers 
showed food pictures to help participants select serving size. On 
the basis of responses to the FFQ, average daily consumption 
of nutrients was calculated with food composition database 
published by the Rural Development Administration of Korea 
[30]. A previous study reported comparison of dietary intake by 
the FFQ and dietary record [31].
Statistical analysis
According to the FTO rs9939609 genotypes such as TT, TA, 
and AA, we calculated descriptive statistics for characteristics, 
which were examined at baseline. Distribution of categorical 
characteristics was evaluated by chi-square tests and continuous 
variables were compared by the analysis of covariance 
(ANCOVA) procedure with Scheffe's post-hoc tests. To test 
associations of the FTO genotypes and lifestyle-related factors 
with MS incidence, pooled logistic regression analysis was used. 
Compared with the major allele homozygote as a reference, the 
multivariate relative odds (RO), which is also called odds ratio, 
of MS incidence and its 95% confidence interval (CI) were 
obtained. If a 95% confidence interval does not contain 0, a 
P-value is considered less than 0.05. In multivariate models, 
covariates including age (continuous), sex, BMI (continuous), 
income (monthly wage of < 10
6  or  ≥10
6 won), occupation 
(office job, non-office job, or others), educational level (< 9 or 
≥9 years), smoking status (never smoker, former smoker, current 
smoker; < 10 cigarettes per year, 10-19 cigarettes per year, 20+ 
cigarettes per year), alcohol intake (abstainers, current alcohol 
consumption; < 15.1 g, 15.1-30, > 30 g/day), physical activity 
(quartiles of MET-hours/day), total energy intake (quartiles), 
energy-adjusted intake of carbohydrate or fat (quartiles), and 
study site were taken into account. To evaluate interactions 
between the genotypes and dichotomized variables of BMI (< 
29 or ≥29 kg/m
2) and lifestyle-related factors, such as smoking 
status (smoking or non-smoking), alcohol drinking (alcohol 
drinking or non-drinking), physical activity (the bottom quartile 
or other quartiles), total energy intake (the bottom quartile or 
other quartiles), and energy-adjusted intake of carbohydrate or 
fat (the bottom quartile or other quartiles), an interaction term 
for each of lifestyle factors was entered into logistic regression 
analysis. In interaction models, the TA and AA genotype groups 
were combined because the AA frequency was extremely rare. 
To investigate which MS component plays a more significant 
role in overall MS incidence, each of the components was 
included in MS cases as a requisite trait and then interaction 
models were fitted. All statistical analyses were undertaken using 
SAS program (SAS 9.1.3, SAS Institute, Cary, NC, USA).
Results
During a 6-year follow-up period, 1,487 cases (720 men and 
767 women) of MS incidence were newly identified. Table 1 
demonstrates characteristics of the study participants according 
to the FTO rs9939609 genotypes. Frequencies of the TT, TA, 
and AA genotypes were shown as 0.78, 0.21, and 0.02, 
respectively. The mean BMI was significantly higher in carriers 
with TA than in those with other genotypes. Demographic or Inkyung Baik and Chol Shin 81
Fig. 1. Relative odds of MS incidence by joint effects of the FTO rs9939609 
genotypes and BMI. Abbreviation:  MS,  metabolic  syndrome;  BMI,  body  mass 
index;  RO,  relative  odds 
1)Data  are  adjusted  for  age  (continuous),  sex,  BMI 
(continuous), income (monthly wage of <10
6 or ≥10
6 won), occupation (office job, 
non-office job, or others), educational level (<9 or ≥ 9 years), smoking status (never 
smoker, former smoker, current smoker; <10 cigarettes per year, 10-19 cigarettes 
per  year,  20+  cigarettes  per  year),  alcohol  intake  (abstainers, c u r r e n t  a l c o h o l  
consumption;  < 15.1g,  15.1-30,  > 30  g/day),  physical  activity  (quartiles  of 
MET-hours/day),  total  energy  intake  (quartiles),  energy-adjusted  intake  of 
carbohydrate  or  fat  (quartiles),  and  study  site.
Models
RO (95% CI) of MS incidence by 
the genotypes
TT TA + AA
Among all participants
No. of cases/No. at risk 1,156/7,893 331/2,272
Age adjusted reference 1.00 (0.88, 1.15)
Multivariate adjusted
1) reference 0.92 (0.80, 1.06)
Stratification by BMI
<2 3  k g / m
2 No. of cases/No. at risk 297/3,527 64/898
Age adjusted reference 0.84 (0.63, 1.11)
Multivariate adjusted
1) reference 0.77 (0.57, 1.03)
23-24.9 kg/m
2 No. of cases/No. at risk 351/2,309 95/660
Age adjusted reference 0.94 (0.73, 1.20)
Multivariate adjusted
1) reference 0.89 (0.69, 1.15)
25-26.9 kg/m
2 No. of cases/No. at risk 279/1,274 97/466
Age adjusted reference 0.94 (0.72, 1.22)
Multivariate adjusted
1) reference 0.99 (0.75, 1.30)
27-28.9 kg/m
2 No. of cases/No. at risk 159/531 39/160
Age adjusted reference 0.78 (0.52, 1.17)
Multivariate adjusted
1) reference 0.81 (0.52, 1.26)
≥29 kg/m
2 No. of cases/No. at risk 70/252 36/88
Age adjusted reference 1.86 (1.11, 3.12)
Multivariate adjusted
1) reference 2.12 (1.17, 3.85)
Abbreviation:  MS,  metabolic  syndrome;  BMI,  body  mass  index
1) Data are adjusted for age (continuous), sex, BMI (continuous), income (monthly 
wage of < 10
6 or ≥10
6 won), occupation (office job, non-office job, or others), 
educational level (<9 or ≥ 9 years), smoking status (never smoker, former smoker, 
current smoker; <10 cigarettes per year, 10-19 cigarettes per year, 20+ cigarettes 
per  year),  alcohol  intake  (abstainers,  current  alcohol  consumption;  < 15.1g, 
15.1-30, > 30 g/day), physical activity (quartiles of MET-hours/day), total energy 
intake  (quartiles),  energy-adjusted  intake  of  carbohydrate  or  fat  (quartiles),  and 
study  site.
Table 2. Associations between the FTO rs9939609 genotypes and MS incidence
during a 6-year follow-up period
Lifestyle-related factors
RO (95% CI) of MS incidence
Age and BMI adjusted Multivariate adjusted
1)
BMI
<2 3  k g / m
2 reference reference
23-24.9 kg/m
2 2.24 (1.92, 2.60) 2.52 (2.16, 2.94)
25-26.9 kg/m
2 3.50 (2.98, 4.11) 3.97 (3.36, 4.68)
27-28.9 kg/m
2 5.28 (4.32, 6.46) 6.05 (4.91, 7.45)
≥29 kg/m
2 5.75 (4.44, 7.44) 6.24 (4.79, 8.13)
Smoking status
Nonsmoking reference reference
Light smoking 1.37 (1.13, 1.68) 1.33 (1.08, 1.65)
Moderate smoking 1.40 (1.18, 1.65) 1.32 (1.09, 1.60)
Heavy smoking 2.15 (1.61, 2.86) 1.89 (1.39, 2.57)
Alcohol drinking status
Nondrinking reference reference
Light drinking 0.99 (0.87, 1.14) 0.98 (0.85, 1.13)
Moderate drinking 1.11 (0.90, 1.37) 1.10 (0.87, 1.39)
Heavy drinking 1.57 (1.30, 1.88) 1.46 (1.18, 1.81)
Physical activity
Q1 reference reference
Q2 0.82 (0.69, 0.96) 0.85 (0.72, 0.99)
Q3 0.84 (0.72, 0.99) 0.84 (0.71, 0.99)
Q4 1.17 (0.99, 1.37) 0.85 (0.71, 1.02)
Energy intake
Q1 reference reference
Q2 0.92 (0.78, 1.08) 0.98 (0.82, 1.16)
Q3 0.91 (0.77, 1.07) 1.00 (0.84, 1.19)
Q4 0.97 (0.82, 1.14) 0.93 (0.78, 1.10)
Carbohydrate intake
2)
Q1 reference reference
Q2 0.81 (0.68, 0.95) 0.71 (0.55, 0.90)
Q3 0.97 (0.82, 1.14) 0.78 (0.57, 1.07)
Q4 1.08 (0.92, 1.28) 0.74 (0.50, 1.08)
Fat intake
2)
Q1 reference reference
Q2 0.88 (0.75, 1.03) 0.98 (0.77, 1.25)
Q3 0.82 (0.70, 0.97) 0.97 (0.71, 1.33)
Q4 0.86 (0.73, 1.02) 0.79 (0.53, 1.15)
Abbreviation:  MS,  metabolic  syndrome;  BMI,  body  mass  index;  Q,  quartile
1) Data are adjusted for age (continuous), sex, BMI (continuous), income (monthly 
wage of < 10
6 or ≥10
6 won), occupation (office job, non-office job, or others), 
educational level (<9 or ≥ 9 years), smoking status (never smoker, former smoker, 
current smoker; <10 cigarettes per year, 10-19 cigarettes per year, 20+ cigarettes 
p e r  y e a r ) ,  a l c o h o l  i n t a k e  ( a b s t a i n e r s ,  c u r r e n t  a l c o h o l  c o n s u m p t ion;  < 15.1g, 
15.1-30, > 30 g/day), physical activity (quartiles of MET-hours/day), total energy 
intake  (quartiles),  energy-adjusted  intake  of  carbohydrate  or  fat  (quartiles),  and 
study  site.
2) Energy-adjusted  intake
Table 3. Associations of BMI and lifestyle-related factors with MS incidence
lifestyle-related variables were not significantly different across 
the genotypes, although carriers with AA were younger and more 
likely to be physically active than those with TT and TA.
Tables 2 shows the association between the rs9939609 genotypes 
and MS incidence with results stratified by BMI. After taking 
into account age, BMI, and further potential risk factors of MS, 
no association was observed among all study participants, 82 FTO polymorphism and metabolic syndrome incidence
Lifestyle-related 
factors
RO
1) (95% CI) of MS incidence by the 
genotypes P-value for
interaction
TT TA+AA
BMI
<2 9  k g / m
2 reference 0.95 (0.83, 1.09) < 0.05
≥29 kg/m
2  2.34 (1.75, 3.12) 4.22 (2.73, 6.54)
Smoking status
Nonsmoking reference 1.01 (0.87, 1.18) 0.51
Smoking 1.23 (1.03, 1.48) 1.11 (0.82, 1.51)
Alcohol drinking status
Nondrinking reference 1.02 (0.85, 1.24) 0.67
Drinking 1.12 (0.98, 1.29) 1.08 (0.89, 1.32)
Physical activity
Q1 reference 0.91 (0.69, 1.18) 0.43
Q2-Q4 0.82 (0.71, 0.95) 0.84 (0.70, 1.02)
Energy intake
Q1 reference 0.94 (0.72, 1.25) 0.69
Q2-Q4 1.05 (0.90, 1.22) 1.06 (0.87, 1.27)
Carbohydrate intake
2)
Q1 reference 0.84 (0.64, 1.11) 0.17
Q2-Q4 0.87 (0.74, 1.02) 0.91 (0.75, 1.11)
Fat intake
2)
Q1 reference 0.90 (0.69, 1.18) 0.41
Q2-Q4 0.93 (0.80, 1.09) 0.96 (0.79, 1.16)
Abbreviation:  MS,  metabolic  syndrome;  BMI,  body  mass  index;  Q,  quartile
1) Data are adjusted for age (continuous), sex, BMI (continuous), income (monthly 
wage of < 10
6 or ≥10
6 won), occupation (office job, non-office job, or others), 
educational level (<9 or ≥ 9 years), smoking status (dichotomous), alcohol intake 
(dichotomous), physical activity (dichotomous), total energy intake (dichotomous), 
energy-adjusted  intake  of  carbohydrate  or  fat  (dichotomous),  and  study  site.
2) Energy-adjusted  intake
Table 4. Relative odds of MS incidence by joint effects of the FTO rs9939609
genotypes, BMI, and lifestyle-related factors
Requisite 
trait of MS 
incidence 
cases
BMI
categories
Multivariate RO
1) ( 95% CI) by the 
genotypes P-value for
interaction
TT TA+AA
Large waist < 29 kg/m
2 Reference 1.01 (0.87, 1.17) < 0.05
≥29 kg/m
2  2.84 (2.11, 3.81) 5.07 (3.25, 7.91)
High 
triglyceride
<2 9  k g / m
2 reference 0.94 (0.80, 1.12) 0.12
≥29 kg/m
2  1.91 (1.30, 2.81) 3.16 (1.78, 5.62)
Low HDL 
cholesterol
<2 9  k g / m
2 reference 0.97 (0.83, 1.13) 0.10
≥29 kg/m
2  2.33 (1.70, 3.18) 3.67 (2.26, 5.96)
High blood 
pressure
<2 9  k g / m
2 reference 0.92 (0.78, 1.10) < 0.05
≥29 kg/m
2  2.59 (1.86, 3.62) 5.10 (3.12, 8.34)
High glucose < 29 kg/m
2 reference 0.99 (0.79, 1.23) 0.44
≥29 kg/m
2  2.23 (1.38, 3.61) 3.14 (1.46, 6.75)
Abbreviation:  MS,  metabolic  syndrome;  BMI,  body  mass  index
1) Data are adjusted for age (continuous), sex, income (monthly wage of < 10
6 or 
≥1 0
6 won), occupation (office job, non-office job, or others), educational level 
(< 9  or  ≥ 9  years),  smoking  status  (never  smoker,  former  smoker,  current 
smoker; < 10 cigarettes per year, 10-19 cigarettes per year, 20+ cigarettes per 
year), alcohol intake (abstainers, current alcohol consumption; < 15.1g, 15.1-30, 
> 30  g/day),  physical  activity  (quartiles  of  MET-hours/day),  total  energy  intake 
(quartiles),  energy-adjusted  intake  of  carbohydrate  or  fat  (quartiles),  and  study 
site.
Table 5. Relative odds of MS traits by joint effects of the FTO rs9939609 
genotypes and BMI
particularly among those with BMI less than 29 kg/m
2. Among 
individuals with BMI of 29 kg/m
2 or greater, however, carriers 
of the A-risk allele had a markedly significant increase in RO 
of MS incidence compared with non-carriers.
Fig. 1 demonstrates joint effects of the rs9939609 genotypes 
and BMI on MS incidence. Among individuals who had BMI 
less than 29 kg/m
2, multivariate ROs of MS incidence were 
similar, regardless of the genotypes, within the same categories 
of BMI. In addition, carriers of the TT genotype with BMI of 
29 kg/m
2 or greater showed a RO similar to that observed among 
persons with BMI of 25 to 28.9 kg/m
2; ROs (95% CI) were 
2.91 (2.53, 3.34) for the TT carriers with BMI of 25 to 28.9 
kg/m
2, 3.30 (2.46, 4.44) for the TT carriers with BMI of 29 kg/m
2 
or greater, and 2.57 (2.08, 3.18) for carriers of the A-risk allele 
with BMI of 25 to 28.9 kg/m
2 compared with the TT carriers 
with BMI less than 25 kg/m
2. But, carriers of the A-risk allele 
with BMI of 29 kg/m
2 or greater showed an approximately 6-fold 
higher RO (95% CI: 3.82 to 9.30) when using the same reference.
In Table 3, the associations of BMI and lifestyle-related factors 
with MS incidence are presented. As expected, increasing BMI 
was strongly associated with MS incidence. Heavy smoking as 
well as light to moderate smoking significantly elevated ROs 
of MS incidence. While light to moderate alcohol drinking did 
not elevate ROs, heavy drinking significantly did when compared 
with non-drinkers. Compared with individuals in the bottom 
quartile of physical activity, those in other higher quartiles 
showed about 15% reduced ROs of MS incidence. Total calorie 
intake and calorie-adjusted fat intake were not significantly 
associated with MS incidence. Compared with individuals in the 
bottom quartile of calorie-adjusted carbohydrate intake, those in 
other higher quartiles showed 22% to 29% reduced ROs of MS 
incidence after controlling for potential risk factors of MS.
Table 4 shows the effects of dichotomous variables of BMI 
and lifestyle-related factors on the association between the 
rs9939609 genotypes and MS incidence. BMI was dichotomized 
using 29 kg/m
2 because this cutoff point was found to be a 
threshold beyond which significantly increased ROs of MS 
incidence. As presented in Table 4, BMI significantly modified 
the association between the rs9939609 variants and MS incidence 
(P-value for interaction < 0.05) while lifestyle-related factors did 
not. Regardless of the FTO genotypes, however, physical activity 
appeared to play a modifiable role in protecting MS occurrence 
because more active persons were likely to have lower ROs of 
MS incidence compared with those in the bottom quartile of 
MET-hours/day (Table 4).
Because only BMI was found to be a significant modifier, we 
further evaluated which MS trait is mainly influenced by the 
interaction between the rs9939609 genotypes and BMI. As 
indicated in Table 5, when MS clustering included either central 
obesity or high blood pressure as a requisite trait, BMI 
significantly modified the association between the genotypes and 
MS incidence (P-value for interaction < 0.05). Among obese 
persons with BMI of 29 kg/m
2 or greater, carriers with the A-risk Inkyung Baik and Chol Shin 83
allele showed approximately 2-fold higher ROs of having high 
blood pressure trait compared with non-carriers even after taking 
BMI into account.
Discussion
A 6-year prospective cohort study including middle-aged and 
older Korean adults observed a significant association between 
the FTO rs9939609 variants and MS incidence only among obese 
persons with BMI of 29 kg/m
2 or greater. After taking into 
account potential risk factors of MS, carriers of the A-risk allele 
at rs9939609 with BMI of 29 kg/m
2 or greater showed an 
approximately 6-fold higher RO of MS incidence compared with 
the TT carriers with BMI less than 25 kg/m
2. Compared with 
the same reference group, however, individuals with BMI of 29 
kg/m
2 or greater carrying the TT genotype showed a 3-fold higher 
RO, and those with BMI of 25 to 28.9 kg/m
2 also showed similar 
magnitude in MS risk regardless of the genotypes. Thus, high 
BMI significantly modified the association between the rs9939609 
variants and MS incidence, but lifestyle-related factors, including 
smoking, alcohol drinking, physical activity, and calorie intake 
did not.
The fat mass and obesity associated gene is located on 
chromosome 16q12.2 containing 9 exons and encodes a 2-oxoglu-
tarate-dependent nucleic acid demethylase. Its postulated biological 
roles include the hypothalamic control of energy homeostasis 
[32] and food intake [33], the regulation of body fat content 
via adipocyte lipolysis [34], and cerebrocortical regulation of 
insulin [35]. Although this gene’s genuine function in human 
obesity is still largely unclear, it is one of the most recognized 
genetic loci for the commonly occurring form of obesity. Several 
population genetic studies showed consistent replications [2-5], 
especially among populations from European ancestry, but 
studies for Asian populations reported conflicting data on the 
association with obesity [5-7] and obesity-related traits [23,25]. 
Ethnic discrepancies in previous findings may be partly due to 
low minor allele frequencies of the FTO variants. For example, 
the rs9939609 A-risk allele frequency ranges 12 to 20% in East 
Asians [6-8,10,12,18], while it is approximately 40% among 
populations from European ancestry [5]. In addition, lower levels 
of obesity in Asians than in other ethnic groups may have led 
to weak or null associations between the FTO variants and BMI 
[9]. Because of similar reasons, earlier studies among non- 
Caucasians, but not all studies, might have had limited statistical 
power to detect associations between the FTO variants and MS 
traits [23-25]. One study in the population with different non- 
Caucasian ethnicities demonstrated that carriers with the 
rs9939609 A-risk allele were more likely to have MS [18]. In 
our study, a null association between the rs9939609 SNP and 
MS incidence was observed among all participants, but a 
significantly elevated risk associated with carrying the A-risk 
allele was uncovered among persons with BMI of 29 kg/m
2 or 
greater. Thus, only BMI was found as a significant modifier in 
the association between the FTO variants and MS risk. Our data 
suggest that not all carriers with the FTO risk allele become 
obese or diagnosed with MS. In particular, carriers of the A-risk 
allele with BMI of 25 to 28.9 kg/m
2, which is in the range of 
obesity defined for Asians, did not show increased MS risks 
compared with non-carriers whose BMI was in the similar range. 
The effects of the A-risk allele appeared among persons with 
BMI 29 kg/m
2 or greater. This fatness itself elevated the MS 
risk and further increased the risk when accompanied with a 
genetic factor such as having a FTO risk allele. On the basis 
of our findings, we speculate that there may be a threshold effect 
of BMI on the FTO variants in triggering certain metabolic 
disturbances and leading to MS incidence. Freathy et al. [20] 
reported that carrying the rs9939609 A-risk allele is significantly 
associated with higher triglycerides and lower HDL cholesterol, 
but not with LDL cholesterol. However, the significant associa-
tion was nullified after adjustment of BMI [20] similarly shown 
in our findings. Instead, our results focusing on MS components 
imply that central obesity and high blood pressure may be 
potential components that underlie the association between FTO, 
BMI, and MS. Pausova et al. [17] hypothesized a biological role 
of FTO in the regulation of sympathetic vasomotor tone regarding 
the association between the FTO variants and blood pressure 
independent of BMI. Supporting this hypothesis, an experimental 
study showed that FTO-deficient mice keep leanness with 
systemic sympathetic activation [36] and an epidemiologic study 
observed a significant relation between the FTO variant and 
mortality due to diseases of the nervous system [37]. In addition, 
sympathetic vasomotor tone is elevated with hyperactivity of 
paraventricular nucleus neurons in the hypothalamus [38], where 
FTO is highly expressed.
Some, but not all [39,40], recent studies have demonstrated 
interactions between FTO and environmental factors, such as 
dietary intake [41] or physical activity [42,43], in association 
with obesity among adults. Sonestedt et al. [41] reported that 
energy-adjusted macronutrient such as fat or carbohydrate intake 
significantly modifies the association between the rs9939609 
variants and obesity and suggested that FTO and high fat diet 
may exert synergistic effects on obesity. They have also pointed 
out that low physical activity may accentuate the genetic effects 
on the susceptibility of obesity as other studies similarly 
suggested [42,43]. So far, no data is available on the interaction 
between FTO and environmental factors in the association with 
MS incidence. One study has reported the association between 
the rs9939609 variants and MS incidence [15]. In the present 
study, we first convey data on the effects of a broad range of 
lifestyle-related factors on the association between FTO and MS 
incidence.
Several strengths and limitations need to be considered when 
our results are interpreted. Our study comprised population-based 
cohorts, which were derived from the well-defined homogenous 
population of Koreans, and used standardized methods to identify 84 FTO polymorphism and metabolic syndrome incidence
outcomes. Some limitations, however, are apparent. The follow- 
up rate for 6 years was 65%, but discrepancies in the distribution 
of BMI or the FTO polymorphisms were not significant between 
participants lost during follow-up and those kept in the long-term 
study. Our findings may not apply to other ethnicities, but may 
provide significant implications for Asians. Thus, further evalua-
tions for other Asian groups are warranted. In addition, more 
data are called for to characterize the effects of other lifestyle- 
related factors, including detailed nutrient intake or obesity- 
related behaviors, on the association between FTO and MS risk. 
On the basis of our findings on the additive effects of smoking 
and sedentary lifestyle on MS risks regardless of the FTO 
polymorphisms, cessation of smoking and active lifestyle are 
recommended to reduce the MS risk as well as to prevent 
potentially cardiovascular disease. Moreover, because individuals 
who carry the FTO risk alleles and have BMI of 29 kg/m
2 or 
greater, in particular, are considered a high risk population, they 
may need intensive weight loss regimens to prevent the 
development of MS.
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